Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL

British Journal of Haematology
Eva LandmannBerlin-Frankfurt-Münster Group

Abstract

The emergence of non-Hodgkin lymphoma (NHL) during childhood and adolescence as a secondary neoplasm (SN) after previous cancer other than NHL is rare. To describe the characteristics and outcome of NHL following previous cancer other than NHL in children and adolescents, this study analysed the data of patients reported to the NHL-Berlin-Frankfurt-Münster study centre from 1986 to 2005. Out of the total of 2968 NHL-patients registered, 11 patients were assessed as having suffered from NHL as a proven SN. Four additional children had most likely suffered from NHL as an SN, but a late relapse of the first neoplasm could not be ruled out unequivocally. In the patients with proven SN, median age at diagnosis of the primary malignancy was 3.9 years (range 2-11.7). The median age at diagnosis of NHL was 7.6 years (range 4.7-18). Only lymphoblastic (n = 7) and diffuse large B-cell (n = 4) lymphomas were diagnosed as SN. The estimated 5-year event-free survival from time of diagnosis of NHL was 91% [95% confidence interval (CI) 74-100%] in patients with proven SNs and 84% (95% CI 63-100%) when the patients with probable SNs were included in the analysis. We concluded that secondary NHL in children and adolescents confers a favourable ...Continue Reading

References

Feb 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K WinklerV Gerein
Feb 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A ReiterH Riehm
Feb 2, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G Schellong
Apr 20, 2001·Journal of the National Cancer Institute·J P NegliaL L Robison
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beate TimmermannMichael Bamberg
Oct 5, 2002·Cancer·Gemma GattaFranco Berrino
Dec 20, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GattaUNKNOWN EUROCARE Working Group
Nov 10, 2004·British Journal of Cancer·H C JenkinsonM C G Stevens
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagen Graf EinsiedelGünter Henze
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Birgit BurkhardtAlfred Reiter
Sep 16, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Anne-Sophie CarretUNKNOWN Canadian Pediatric Brain Tumour Consortium
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ursula CreutzigDirk Reinhardt
Dec 5, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M C Cardous-UbbinkF E van Leeuwen

❮ Previous
Next ❯

Citations

Feb 24, 2009·Leukemia & Lymphoma·Peter McLaughlin, Jonathan W Friedberg
Mar 5, 2020·Revista da Associação Médica Brasileira·Maria Christina L OliveiraMarcos B Viana
Jun 3, 2021·Cancers·Sebastian Zahnreich, Heinz Schmidberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.